
Gerard M. Doherty, MD
Surgeon-in-Chief and Crowley Family Endowed Chair of Surgery, Brigham and Women’s Hospital
Surgeon-in-Chief, Mass General Brigham Cancer
Moseley Professor of Surgery, Harvard Medical School
Dr. Doherty is a specialist in surgery, with a particular focus on endocrine surgery. Since 2016, Dr. Doherty has held the Moseley Professor of Surgery at Harvard Medical School and serves as the Crowley Family Endowed Chair and surgeon-in-chief at Brigham and Women’s Hospital and Mass General Brigham Cancer Institute.
Dr. Doherty began his research in the 1990s in the laboratory, studying interferon gamma, cytokines and TNF-alpha in tumors. Alongside his clinical career, he has transitioned to clinical and translational studies of endocrine tumors, particularly pancreatic NETs, adrenal cortical cancers, hyperparathydoidism and MEN1.
He is involved in the work of consensus statements and guidelines in endocrine tumors and has held leadership roles in many professional associations, including president of the American Association of Endocrine Surgeons (AAES) and president of the International Association of Endocrine Surgeons (IAES). For more than 20 years, he has collaborated closely with researchers at the Faculty of Medicine of Uppsala University, enabling visiting professorships at both Harvard and the University of Michigan, thereby enabling scientific collaboration on clinical materials for rare diseases.